PainReform Provides Year-End Business Update
Reports continued enrollment in the second part of the Phase 3 clinical trial in bunionectomy Remains on track to announce […]
Reports continued enrollment in the second part of the Phase 3 clinical trial in bunionectomy Remains on track to announce […]
— Maturing into clinical-stage company; on-track to file IND application or CTA for PM359 in 1H 2024, with initial data […]
BOSTON, March 01, 2024 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights […]
SALT LAKE CITY, March 01, 2024 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology […]
Atlantica Reports 2023 Financial Results Net profit for 2023 attributable to the Company was $43.4 million, compared with a net […]
EDINBURG, Va., March 01, 2024 (GLOBE NEWSWIRE) — Shenandoah Telecommunications Company (“Shentel” or the “Company”) (Nasdaq: SHEN) announced that it […]
BEIJING, China, March 01, 2024 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), […]
Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 01 March 2024) Immunocore […]
ANDOVER, Mass., March 01, 2024 (GLOBE NEWSWIRE) — Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a technology company that delivers mission-critical […]
LATHAM, N.Y., March 01, 2024 (GLOBE NEWSWIRE) — Today, Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen […]